Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 227
7
Diseases
45
Unique genes
0.101
Avg. similarity score
Absence epilepsy
Most-connected disease (5 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Absence epilepsy
Childhood absence epilepsy
Ataxia
Conn syndrome
Idiopathic generalized epilepsy
Synovial disorder
Juvenile absence epilepsy
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Absence epilepsy | 5 | 5 | 7 |
| Childhood absence epilepsy | 5 | 5 | 10 |
| Ataxia | 3 | 3 | 21 |
| Conn syndrome | 2 | 2 | 1 |
| Idiopathic generalized epilepsy | 2 | 2 | 12 |
| Synovial disorder | 2 | 2 | 6 |
| Juvenile absence epilepsy | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| CACNA1H | 3 / 7 | Absence epilepsy, Childhood absence epilepsy, Conn syndrome |
| GABRA1 | 3 / 7 | Ataxia, Childhood absence epilepsy, Idiopathic generalized epilepsy |
| GABRB3 | 3 / 7 | Absence epilepsy, Childhood absence epilepsy, Synovial disorder |
| SLC2A1 | 3 / 7 | Ataxia, Childhood absence epilepsy, Idiopathic generalized epilepsy |
| CACNA1A | 2 / 7 | Absence epilepsy, Ataxia |
| CACNA2D2 | 2 / 7 | Absence epilepsy, Ataxia |
| CACNB4 | 2 / 7 | Ataxia, Idiopathic generalized epilepsy |
| EFHC1 | 2 / 7 | Absence epilepsy, Juvenile absence epilepsy |
| JRK | 2 / 7 | Absence epilepsy, Childhood absence epilepsy |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Nicotine addiction | KEGG | 9 / 41 | 58.6× | 1.99e-14 | 5.81e-12 ✓ sig. |
| GABA receptor activation | Reactome | 7 / 16 | 117× | 7.09e-14 | 1.87e-11 ✓ sig. |
| GABAergic synapse | KEGG | 10 / 89 | 30.0× | 7.67e-13 | 1.71e-10 ✓ sig. |
| Morphine addiction | KEGG | 9 / 91 | 26.4× | 3.89e-11 | 6.16e-9 ✓ sig. |
| Retrograde endocannabinoid signaling | KEGG | 9 / 149 | 16.1× | 3.31e-9 | 3.27e-7 ✓ sig. |
| Presynaptic depolarization and calcium channel opening | Reactome | 4 / 12 | 89.0× | 8.33e-8 | 5.58e-6 ✓ sig. |
| HCN channels | Reactome | 3 / 4 | 200× | 1.96e-7 | 1.18e-5 ✓ sig. |
| Phase 0 - rapid depolarisation | Reactome | 5 / 44 | 30.3× | 5.72e-7 | 3.00e-5 ✓ sig. |
| Taste transduction | KEGG | 6 / 86 | 18.6× | 7.36e-7 | 3.73e-5 ✓ sig. |
| Neuroactive ligand-receptor interaction | KEGG | 9 / 370 | 6.5× | 7.53e-6 | 2.64e-4 ✓ sig. |
| Regulation of insulin secretion | Reactome | 3 / 16 | 50.0× | 2.66e-5 | 7.53e-4 ✓ sig. |
| Phase 2 - plateau phase | Reactome | 3 / 25 | 32.0× | 1.07e-4 | 2.37e-3 ✓ sig. |
| Arrhythmogenic right ventricular cardiomyopathy | KEGG | 4 / 86 | 12.4× | 2.92e-4 | 5.25e-3 ✓ sig. |
| Hypertrophic cardiomyopathy | KEGG | 4 / 99 | 10.8× | 4.99e-4 | 7.96e-3 ✓ sig. |
| Dilated cardiomyopathy | KEGG | 4 / 105 | 10.2× | 6.24e-4 | 9.49e-3 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| monoatomic ion transport | GO:0006811 | 24 / 667 | 14.9× | 2.27e-23 | 5.98e-20 ✓ sig. |
| monoatomic ion transmembrane transport | GO:0034220 | 20 / 404 | 20.6× | 6.02e-22 | 1.28e-18 ✓ sig. |
| gamma-aminobutyric acid signaling pathway | GO:0007214 | 9 / 30 | 125× | 1.60e-17 | 1.80e-14 ✓ sig. |
| chloride transmembrane transport | GO:1902476 | 11 / 114 | 40.1× | 2.27e-15 | 1.67e-12 ✓ sig. |
| chloride transport | GO:0006821 | 10 / 81 | 51.3× | 3.72e-15 | 2.64e-12 ✓ sig. |
| synaptic transmission, GABAergic | GO:0051932 | 8 / 35 | 94.9× | 1.31e-14 | 8.37e-12 ✓ sig. |
| inhibitory synapse assembly | GO:1904862 | 7 / 25 | 116× | 1.34e-13 | 7.22e-11 ✓ sig. |
| regulation of postsynaptic membrane potential | GO:0060078 | 8 / 59 | 56.3× | 1.19e-12 | 5.38e-10 ✓ sig. |
| chemical synaptic transmission | GO:0007268 | 10 / 236 | 17.6× | 1.85e-10 | 4.98e-8 ✓ sig. |
| regulation of membrane potential | GO:0042391 | 7 / 85 | 34.2× | 1.24e-9 | 2.71e-7 ✓ sig. |
| transmembrane transport | GO:0055085 | 11 / 557 | 8.2× | 6.05e-8 | 7.96e-6 ✓ sig. |
| potassium ion import across plasma membrane | GO:1990573 | 5 / 46 | 45.1× | 8.20e-8 | 1.02e-5 ✓ sig. |
| cellular response to histamine | GO:0071420 | 3 / 6 | 208× | 2.60e-7 | 2.70e-5 ✓ sig. |
| inner ear receptor cell development | GO:0060119 | 3 / 8 | 156× | 7.25e-7 | 6.40e-5 ✓ sig. |
| sodium ion transmembrane transport | GO:0035725 | 6 / 134 | 18.6× | 7.87e-7 | 6.82e-5 ✓ sig. |
Pairs within this cluster, by significance
| Disease A ⇵ | Disease B ⇵ | Similarity score ⇵ | Shared genes ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Absence epilepsy | Childhood absence epilepsy | 0.200 | 3 | 6.89e-9 | 6.09e-8 ✓ sig. |
| Ataxia | Idiopathic generalized epilepsy | 0.097 | 3 | 4.77e-7 | 3.14e-6 ✓ sig. |
| Childhood absence epilepsy | Idiopathic generalized epilepsy | 0.095 | 2 | 2.50e-5 | 1.23e-4 ✓ sig. |
| Absence epilepsy | Ataxia | 0.074 | 2 | 3.70e-5 | 1.79e-4 ✓ sig. |
| Ataxia | Childhood absence epilepsy | 0.067 | 2 | 7.92e-5 | 2.84e-4 ✓ sig. |
| Absence epilepsy | Conn syndrome | 0.125 | 1 | 4.55e-4 | 9.55e-4 ✓ sig. |
| Absence epilepsy | Juvenile absence epilepsy | 0.125 | 1 | 4.55e-4 | 9.55e-4 ✓ sig. |
| Childhood absence epilepsy | Conn syndrome | 0.091 | 1 | 6.49e-4 | 1.22e-3 ✓ sig. |
| Absence epilepsy | Synovial disorder | 0.077 | 1 | 2.72e-3 | 3.65e-3 ✓ sig. |
| Childhood absence epilepsy | Synovial disorder | 0.063 | 1 | 3.89e-3 | 4.94e-3 ✓ sig. |